Albanese, Alberto
 Distribuzione geografica
Continente #
EU - Europa 4.870
NA - Nord America 4.448
AS - Asia 1.002
AF - Africa 29
SA - Sud America 12
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 10.378
Nazione #
US - Stati Uniti d'America 4.432
DE - Germania 1.787
SE - Svezia 793
CN - Cina 717
UA - Ucraina 664
IE - Irlanda 423
IT - Italia 327
FR - Francia 317
GB - Regno Unito 158
FI - Finlandia 138
IN - India 124
TR - Turchia 79
AT - Austria 49
BE - Belgio 49
RU - Federazione Russa 46
PL - Polonia 27
CI - Costa d'Avorio 25
JP - Giappone 24
HK - Hong Kong 22
NL - Olanda 18
ES - Italia 11
CZ - Repubblica Ceca 9
IR - Iran 9
AU - Australia 8
BG - Bulgaria 8
CA - Canada 8
RO - Romania 8
SG - Singapore 8
BR - Brasile 7
GR - Grecia 6
HU - Ungheria 6
MX - Messico 6
EU - Europa 5
TW - Taiwan 5
DK - Danimarca 4
MD - Moldavia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
VN - Vietnam 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
KZ - Kazakistan 2
MT - Malta 2
PT - Portogallo 2
TH - Thailandia 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.378
Città #
Chandler 857
Ashburn 513
Dublin 422
San Mateo 334
Jacksonville 312
Nanjing 203
Wilmington 176
Lawrence 115
Dearborn 111
Boston 108
Ann Arbor 104
Woodbridge 100
Nürnberg 85
Princeton 82
Redwood City 81
Izmir 73
Milan 67
Nanchang 67
New York 65
Houston 64
Shenyang 64
Lancaster 61
Cattolica 57
Beijing 56
Seattle 52
Fairfield 50
Brussels 49
Norwalk 49
Mountain View 47
University Park 45
Bremen 41
Hangzhou 37
Jiaxing 37
Tianjin 37
Hebei 35
Detroit 34
Redmond 33
Changsha 32
Marseille 32
Boardman 27
Kunming 27
Pune 27
Abidjan 25
Zhengzhou 21
Falls Church 19
Kraków 19
Hong Kong 18
Simi Valley 18
Rome 17
Chicago 16
Hefei 15
Munich 15
Ningbo 15
Washington 15
Ypsilanti 15
Leawood 14
Fremont 13
Jinan 11
Trieste 9
Edinburgh 8
Fuzhou 8
Lanzhou 8
London 8
Guangzhou 7
Phoenix 7
Taizhou 7
Budapest 6
Changchun 6
Costa Mesa 6
Millbury 6
Shanghai 6
Warsaw 6
Andover 5
Fort Worth 5
Frankfurt am Main 5
San Francisco 5
Tehran 5
Brno 4
Cambridge 4
Chengdu 4
Chisinau 4
Formia 4
Groningen 4
Guidonia Montecelio 4
Indiana 4
Newark 4
Avellino 3
Banha 3
Cologne 3
Faenza 3
Lakeside 3
Moscow 3
Mumbai 3
Niagara Falls 3
Old Bridge 3
Paris 3
San Diego 3
Singapore 3
Sydney 3
Teramo 3
Totale 5.335
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 312
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 140
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 139
Mutation screening of the DYT6/THAP1 gene in Italy 132
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 125
Organization of central nervous system dopaminergic pathways 125
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 123
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 119
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 116
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease 115
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 110
Clinical and genetic characteristics of late-onset Huntington's disease 105
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease 104
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up 99
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 98
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 97
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 95
Analysis of blink rate in patients with blepharospasm 93
Early DEtection of wEaring off in Parkinson disease: the DEEP study 88
Advances in the genetics of primary torsion dystonia 87
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 85
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 84
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 84
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 84
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 83
Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation 82
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 82
Gastroenterologia. 79
Behavioral and personality features in patients with lateralized Parkinson's disease 78
Phenotypic characterisation of DYT13 primary torsion distonia. 77
Abnormal gating of somatosensory inputs in essential tremor. 77
Smooth muscle spasms and sphincters. 77
Botulinum toxin injected in the gastric wall reduces body weight and food intake rats. 77
Attentional networks in Parkinson's disease 77
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 75
Dystonia rating scales: critique and recommendations 74
PINK1 mutations are associated with sporadic early-onset parkinsonism. 74
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 73
A 52-Year-Old Man with Myoclonic Jerks 73
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 71
Management of bladder, prostatic and pelvic floor disorders 71
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in a Italian family with cranial-cervical or upper limb onset. 71
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 70
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 70
Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincter spasms. 69
Choice-option evaluation is preserved in early Huntington and Parkinson's disease 69
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 67
Onset and progression of primary torsion dystonia in sporadic and familial cases 67
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders 67
Primary dystonias 67
EFNS guidelines on diagnosis and treatment of primary dystonias 66
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 66
Dystonic tremor 65
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease 65
Isolated limb dystonia as presenting feature of Parkin disease 65
Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. 64
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome 64
Correlation of cardiovascular autonomic function tests, magnetic resonance brain imaging and clinical features in suspect cases of multiple system atrophy 64
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 63
Aging is associated with a diffuse impairment of forebrain cholinergic neurons 63
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 63
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. 61
Phenomenology and classification of dystonia: a consensus update 60
Primary focal hyperhidrosis in a new family not linked to known loci 59
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 59
Dystonia: diagnosis and management 59
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement 57
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 56
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions 56
Dystonia and tremor: the clinical syndromes with isolated tremor 56
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease 55
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 55
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. 54
Effectiveness of higher doses of botulinum toxin to induce healing in patients eith chronic anal fissure. 54
Age-dependent loss of cholinergic neurones in basal ganglia of rats 54
The natural history of multiple system atrophy: a prospective European cohort study 54
Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers 54
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. 53
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 53
Deep brain stimulation for Parkinson's disease: where do we stand? 52
Acetylcholinesterase and catecholamine distribution in the locus ceruleus of the rat 52
Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode 52
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 52
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease 51
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 51
Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts 51
Reliability and validity of the range of motion scale (ROMS) in patients with abnormal postures 51
Quantitative gait analysis in parkin disease: Possible role of dystonia 51
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 50
"Gluing" phenotypes together: the case of GLUT1 49
Quantitative pharmacohistochemistry of acetylcholinesterase in neostriatum of inbred strains of mice 48
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin 47
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity 47
Discussion of unique properties of botulinum toxins 46
Clinical management of pain and fatigue in Parkinson's disease 46
Locus ceruleus somata contain both acetylcholin esterase and norepinephrine: direct histochemical demonstration on the same tissue section 46
Is this dystonia? 46
Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-ervical or upper limb onset. 46
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation:De novo cases and 3-year follow-up 46
Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. 45
Totale 7.418
Categoria #
all - tutte 39.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019371 0 0 0 0 0 0 0 28 51 77 111 104
2019/20201.374 387 50 45 44 54 121 100 62 96 50 218 147
2020/20211.253 42 161 23 148 164 46 183 20 176 58 210 22
2021/20221.324 187 151 22 44 46 31 20 271 47 59 206 240
2022/20232.544 347 339 229 350 226 299 99 174 326 34 88 33
2023/20241.189 49 547 42 241 51 138 81 40 0 0 0 0
Totale 10.536